Review confirms antidepressant efficacy in post‐MI depression

Esketamine monotherapy efficacious in treatment‐resistant depression
Pubblicazione: (2025)

Age an important variable in response to antidepressants
Pubblicazione: (2025)

Alcohol use history predicts antidepressant response to ketamine
Pubblicazione: (2026)

Impact of antidepressants' serotonin transporter affinity on bleeding events
di: Y. W. Francis Lam
Pubblicazione: (2026)

Stopping antidepressant in pregnancy not linked to adverse postpartum outcomes
Pubblicazione: (2024)

Repetitive TMS more effective than antidepressant switch in nonresponders
Pubblicazione: (2024)

Comparative study of antidepressant deprescribing strategies favors slow tapering
Pubblicazione: (2026)

When both treatments unblinded, psychedelics not more effective than antidepressants
Pubblicazione: (2026)

Small differences in weight gain risk among commonly used antidepressants
Pubblicazione: (2024)

Fast‐acting psychedelic shows antidepressant effects in Phase 2A trial
Pubblicazione: (2025)

Antimicrobial exposure and risk of depression
di: Y. W. Francis Lam
Pubblicazione: (2025)

Pharmacological treatments for psychotic depression
di: Y. W. Francis Lam
Pubblicazione: (2024)

Fremanezumab effective for comorbid migraine and depression
Pubblicazione: (2025)

Pharmacogenomic testing influenced prescribing in patients with depression
Pubblicazione: (2025)

Lumateperone effective as adjunctive therapy in patients with depression
Pubblicazione: (2025)

Postpartum hormonal contraceptives increase risk of depression
Pubblicazione: (2025)

Postpartum use of dexmedetomidine reduces incidence of depression
Pubblicazione: (2024)

Adjunctive aticaprant reduces symptoms in patients with depression
Pubblicazione: (2024)

Control group improvement lower in psilocybin trials for depression
Pubblicazione: (2025)

Antidepressants for bipolar depression do not increase risk of mania
Pubblicazione: (2024)

Mixed results for esmethadone in Phase 3 depression trial
Pubblicazione: (2024)

Adjunctive dextromethorphan/quinidine promising in pilot study for depression
Pubblicazione: (2024)

Oral formulation of ketamine effective for treatment‐resistant depression
Pubblicazione: (2024)

Gepirone ER not linked to sexual dysfunction in patients with depression
Pubblicazione: (2024)

Serial ketamine infusions not effective as adjunctive care for depression
Pubblicazione: (2026)

Study finds association between levonorgestrel exposure, depression
Pubblicazione: (2024)

Trial finds fezolinetant efficacious for vasomotor symptoms in menopause
Pubblicazione: (2025)

Serotonin 4 receptor agonist shows promise in preventing depression
Pubblicazione: (2024)

Decision‐support tool shows promise for treatment retention in depression
Pubblicazione: (2026)

Psilocybin shows mixed results for patients with treatment‐resistant depression
Pubblicazione: (2026)

Fluoxetine improves depressive symptoms in weight‐restored patients with anorexia
Pubblicazione: (2026)

N‐acetylcysteine alone not efficacious for youths with cannabis use disorder
Pubblicazione: (2025)

Ketamine shows long‐term benefit in patients with treatment‐resistant depression
Pubblicazione: (2026)

Treatment of late‐life depression improves cognitive function, review finds
Pubblicazione: (2024)

Ketamine outperforms ECT on cognitive function in patients with treatment‐resistant depression
Pubblicazione: (2026)

Low dose of esketamine after childbirth helps mothers at risk of depression
Pubblicazione: (2024)